首页> 外文会议>Conference on photonic therapeutics and diagnostics IX >Near infrared spectral polarization imaging of prostate cancer tissues using Cybesin: a receptor-targeted contrast agent
【24h】

Near infrared spectral polarization imaging of prostate cancer tissues using Cybesin: a receptor-targeted contrast agent

机译:使用Cybesin:受体靶向的造影剂对前列腺癌组织进行近红外光谱偏振成像

获取原文

摘要

Cybesin, a contrast agent to target cancer cells, was investigated using a near infrared (NIR) spectral polarization imaging technique for prostate cancer detection. The approach relies on applying a contrast agent that can target cancer cells. Cybesin, as a small ICG-derivative dye-peptide, emit fluorescence between 750 run and 900 nm, which is in the "tissue optical window". Cybesin was reported targeting the over-expressed bombesin receptors in cancer cells in animal model and the human prostate cancers over-expressing bombesin receptors. The NIR spectral polarization imaging study reported here demonstrated that Cybesin can be used as an optical biomarker and as a prostate cancer receptor targeted contrast agent.
机译:Cybesin是靶向癌细胞的造影剂,使用近红外(NIR)光谱偏振成像技术研究了前列腺癌的检测。该方法依赖于应用可以靶向癌细胞的造影剂。纤溶酶是一种小的ICG衍生染料肽,在“组织光学窗口”中发出750 nm至900 nm的荧光。据报道,半胱氨酸蛋白酶抑制剂靶向动物模型中癌细胞中过表达的蛙皮素受体,而人前列腺癌则过表达蛙皮素受体。此处报道的NIR光谱偏振成像研究表明Cybesin可用作光学生物标志物和前列腺癌受体靶向的造影剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号